Domov › Rak prostate › Texas › San Antonio
Klinične študije za Rak prostate v San Antonio, TX
28 študij za Rak prostate išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Audie L Murphy VA Hospital, San Antonio
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- NEXT Oncology, San Antonio
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Vključevanje udeležencevFaza 2/3
- Urology San Antonio, San Antonio
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Vključevanje udeležencevFaza 3
- Urology San Antonio, San Antonio
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Vključevanje udeležencevFaza 3
- Research Site, San Antonio
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Vključevanje udeležencevFaza 3
- The Urology Place, San Antonio
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Vključevanje udeležencevFaza 3
- Brooke Army Medical Center, Fort Sam Houston · 4 mi stran
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
Vključevanje udeležencevOpazovalna študija
- University of Texas Health Science Center, San Antonio, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Vključevanje udeležencevFaza 1
- START San Antonio, San Antonio
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Vključevanje udeležencevOpazovalna študija
- The Urology Place, Inc., San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- NEXT Oncology, San Antonio
IDOV-Immune for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- START, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- USA Clinical Trials, San Antonio
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Vključevanje udeležencevFaza 1/2
- UT Health, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology San Antonio, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- START San Antonio, San Antonio
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 3
- Audie L Murphy VA Hospital, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #3, San Antonio
Customized TULSA-PRO Ablation Registry
Vključevanje udeležencevOpazovalna študija
- Urology Place, San Antonio
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Houston, TX76 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN42 študij
- Seattle, WA42 študij
- Washington, DC38 študij
Druge študije v San Antonio
- Nemalicelični pljučni rak59 študij
- Kolorektalni rak46 študij
- Rak dojke46 študij
- Metastatski rak44 študij
- Rak (vse vrste)41 študij
- Debelost40 študij
- Sladkorna bolezen tipa 237 študij
- Prekomerna telesna teža34 študij
- Rak jajčnikov31 študij
- Rak trebušne slinavke31 študij
- Rak endometrija27 študij
- Rak pljuč26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.